Everlife Biomed Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series A1

  • Investors
  • 10

Everlife Biomed General Information

Description

Developer of Sertoli cell technology for regenerative medicine based in Beijing, China. The company uses cell reprogramming to develop Sertoli cells for stem cell research and development, enabling biomedical professionals to deliver more effective stem cell solutions to patients.

Contact Information

Website
www.everlifebiomed.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 208, 2nd Floor, Building 2, Tiandi Linfeng
  • No. 1, Yongtaizhuang North Road, Haidian District
  • Beijing, 100192
  • China
+86 177
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Room 208, 2nd Floor, Building 2, Tiandi Linfeng
  • No. 1, Yongtaizhuang North Road, Haidian District
  • Beijing, 100192
  • China
+86 177

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Everlife Biomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A1) 23-Jun-2025 Completed Generating Revenue
5. Later Stage VC 01-Apr-2024 Completed Generating Revenue
4. Secondary Transaction - Private 21-Dec-2022 Completed Generating Revenue
3. Early Stage VC 01-Jun-2022 Completed Pre-Clinical Trials
2. Early Stage VC 28-Jun-2021 Completed Pre-Clinical Trials
1. Seed Round 25-Feb-2019 Completed Pre-Clinical Trials
To view Everlife Biomed’s complete valuation and funding history, request access »

Everlife Biomed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Everlife Biomed Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Yuanhe Capital Venture Capital Minority
Beijing Weihua Yuanhe Capital Investment Management Center Growth/Expansion Minority
Redhill Capital Growth/Expansion Minority
Ruisheng Equity Venture Capital Minority
CLP Health Industry Fund Asset Manager Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Everlife Biomed FAQs

  • When was Everlife Biomed founded?

    Everlife Biomed was founded in 2018.

  • Where is Everlife Biomed headquartered?

    Everlife Biomed is headquartered in Beijing, China.

  • What is the size of Everlife Biomed?

    Everlife Biomed has 4 total employees.

  • What industry is Everlife Biomed in?

    Everlife Biomed’s primary industry is Biotechnology.

  • Is Everlife Biomed a private or public company?

    Everlife Biomed is a Private company.

  • What is Everlife Biomed’s current revenue?

    The current revenue for Everlife Biomed is .

  • Who are Everlife Biomed’s investors?

    Yuanhe Capital, Beijing Weihua Yuanhe Capital Investment Management Center, Redhill Capital, Ruisheng Equity, and CLP Health Industry Fund are 5 of 10 investors who have invested in Everlife Biomed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process